GBT
Swiss National Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-146,600
| Closed | -$9.98M | – | 2786 |
|
2022
Q3 | $9.98M | Buy |
146,600
+1,500
| +1% | +$102K | 0.01% | 887 |
|
2022
Q2 | $4.64M | Buy |
145,100
+8,000
| +6% | +$256K | ﹤0.01% | 1358 |
|
2022
Q1 | $4.75M | Buy |
137,100
+13,800
| +11% | +$478K | ﹤0.01% | 1468 |
|
2021
Q4 | $3.61M | Hold |
123,300
| – | – | ﹤0.01% | 1676 |
|
2021
Q3 | $3.14M | Hold |
123,300
| – | – | ﹤0.01% | 1754 |
|
2021
Q2 | $4.32M | Sell |
123,300
-3,800
| -3% | -$133K | ﹤0.01% | 1597 |
|
2021
Q1 | $5.18M | Buy |
127,100
+2,200
| +2% | +$89.6K | ﹤0.01% | 1444 |
|
2020
Q4 | $5.41M | Buy |
124,900
+600
| +0.5% | +$26K | ﹤0.01% | 1329 |
|
2020
Q3 | $6.85M | Buy |
124,300
+2,100
| +2% | +$116K | 0.01% | 995 |
|
2020
Q2 | $7.71M | Buy |
122,200
+5,400
| +5% | +$341K | 0.01% | 908 |
|
2020
Q1 | $5.97M | Buy |
116,800
+2,100
| +2% | +$107K | 0.01% | 839 |
|
2019
Q4 | $9.12M | Buy |
114,700
+8,500
| +8% | +$676K | 0.01% | 818 |
|
2019
Q3 | $5.15M | Buy |
106,200
+1,400
| +1% | +$67.9K | 0.01% | 1081 |
|
2019
Q2 | $5.51M | Buy |
104,800
+14,400
| +16% | +$757K | 0.01% | 1065 |
|
2019
Q1 | $4.79M | Buy |
90,400
+3,000
| +3% | +$159K | 0.01% | 1109 |
|
2018
Q4 | $3.59M | Buy |
87,400
+1,500
| +2% | +$61.6K | ﹤0.01% | 1183 |
|
2018
Q3 | $3.26M | Buy |
85,900
+6,900
| +9% | +$262K | ﹤0.01% | 1398 |
|
2018
Q2 | $3.57M | Buy |
79,000
+2,400
| +3% | +$108K | ﹤0.01% | 1319 |
|
2018
Q1 | $3.7M | Buy |
76,600
+2,900
| +4% | +$140K | ﹤0.01% | 1239 |
|
2017
Q4 | $2.9M | Buy |
73,700
+19,000
| +35% | +$748K | ﹤0.01% | 1406 |
|
2017
Q3 | $1.7M | Buy |
54,700
+2,300
| +4% | +$71.4K | ﹤0.01% | 1721 |
|
2017
Q2 | $1.43M | Hold |
52,400
| – | – | ﹤0.01% | 1802 |
|
2017
Q1 | $1.93M | Buy |
52,400
+18,700
| +55% | +$689K | ﹤0.01% | 1594 |
|
2016
Q4 | $487K | Buy |
33,700
+5,600
| +20% | +$80.9K | ﹤0.01% | 2406 |
|
2016
Q3 | $648K | Hold |
28,100
| – | – | ﹤0.01% | 2222 |
|
2016
Q2 | $466K | Buy |
28,100
+15,600
| +125% | +$259K | ﹤0.01% | 2388 |
|
2016
Q1 | $190K | Buy |
12,500
+2,900
| +30% | +$44.1K | ﹤0.01% | 2561 |
|
2015
Q4 | $310K | Buy |
+9,600
| New | +$310K | ﹤0.01% | 2475 |
|